Interfacial interactions of apolipoprotein AI and high density lipoprotein: Overlooked phenomena in blood-material contact

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 1, 2011, Pages 109-115

  Cornelius, Rena M ^a   MacRi, Joseph ^a   Brash, John L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

apolipoprotein AI; immunoblot; lipoproteins; plasma; protein adsorption; SDS PAGE

Indexed keywords

APOLIPOPROTEIN A-I; IMMUNOBLOTS; LIPOPROTEINS; PROTEIN ADSORPTION; SDS-PAGE;

ADSORPTION; BIOLOGICAL MATERIALS; BLOOD; PROTEINS; SURFACE PROPERTIES;

PLASMAS;

ALBUMIN; APOLIPOPROTEIN A1; BIOMATERIAL; BUFFER; HIGH DENSITY LIPOPROTEIN; POLYURETHAN;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; BLOOD; HUMAN; PLASMA; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

ADSORPTION; APOLIPOPROTEIN A-I; HUMANS; LIPOPROTEINS, HDL; MATERIALS TESTING; PLASMA; POLYURETHANES; SURFACE PROPERTIES;

EID: 80051872469     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33169     Document Type: Article

References (51)

1. Cornelius RM, Archambault J, Brash JL,. Identification of apo AI as a major adsorbate on biomaterial surfaces after blood or plasma contact. Biomaterials 2002; 23: 3583-3587. (Pubitemid 34626562)
2. Tian L, Wu X, Fu M, Qin Y, Xu Y, Jia L,. Relationship between plasma apoB concentrations, apoB/apolipoproeinA-I and HDL subclasses distribution. Clin Chim Acta 2008; 388: 148-155. (Pubitemid 350266583)
3. Provost PR, Boucher E, Tremblay Y,. Apo A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids. J Endocrinol 2009; 200: 321-330.
4. Noel-Georis I, Bernard A, Falmagne P, Wattiez R,. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 771: 221-236. (Pubitemid 34457730)
5. Cho CJ, Shan SJ, Winsor E, Diamandis EP,. Proteomic Analysis of Human Amniotic Fluid. Mol Cell Proteomics 2007; 6: 1406-1415. (Pubitemid 47365438)
6. Bresnihan B, Gogarty M, Fitzgerald O, Dayer JM, Burger D,. Apo A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production? Arthritis Res Ther 2004; 6: R563-R566.
7. Kipnis E, Hansen K, Sawa T, Moriyama K, Zurawel A, Ishizaka A, Wiener-Kronish J,. Proteomic analysis of undiluted epithelial lung fluid. Chest 2008; 134: 338-345.
8. Scanu A, Edelstein C, Gordon JI,. Apos of human plasma high density lipoproteins. Biology, biochemistry and clinical significance. Clin Physiol Biochem 1984; 2: 111-122. (Pubitemid 14165581)
9. Brewer HB, Fairwell T, LaRue A, Ronan R, Houser A, Bronzert TJ,. The amino acid sequence of human apoA-I, an apo isolated from high density lipoproteins. Biochem Biophys Res Commun 1978; 80: 623-630. (Pubitemid 8275453)
10. Shoulders CC, Kornblihtt AR, Munro BS, Baralle FE,. Gene structure of human apo Al. Nucleic Acids Res 1983; 11: 2827-2837.
11. Cavigiolio G, Geier EG, Shao B, Heinecke JW, Oda MN,. Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States. J Biol Chem 2010; 285: 18847-18857.
12. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP,. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008; 23: 370-378. (Pubitemid 351787103)
13. Curtiss LK, Valenta DT, Hime NJ, Rye K,. What is so special about Apo AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006; 26: 12-19. (Pubitemid 43732223)
14. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E,. High apo B, low apo A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet 2001; 358: 2026-2033. (Pubitemid 34084825)
15. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L,. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-952. (Pubitemid 39208455)
16. Meisinger C, Loewel H, Mraz W, Koening W,. Prognostic value of apo B AI in the prediction of myocardial infarction in middle-aged men and women: Results from the MONICA/KORA Augsburg cohort study. Eur Heart J 2005; 26: 271-278. (Pubitemid 40222365)
17. Walldius G, Jungner I,. Apo B and Apo A-I: Risk indicators of coronary heart disease and targets of lipid-modifying therapy. J Int Med 2004; 255: 188-205. (Pubitemid 38241363)
18. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R,. Effect of recombinant apo AI Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 2003; 290: 2292-2300. (Pubitemid 37430562)
19. Rader DJ,. High-density lipoproteins as an emerging therapeutic target for atherosclerosis. JAMA 2003; 290: 2322-2324. (Pubitemid 37430567)
20. Chiesa G, Sirtori CR,. Use of recombinant apos in vascular diseases: The case of apo AI. Curr Opin Investig Drugs 2002; 3: 420-426. (Pubitemid 34456061)
21. SemBioSys Genetics Incorporated (AB, Canada), 2008. Access date: Dec 3, 2009. Available at:.
22. Resverlogix Corporation (BC, Canada), 2009. Access date: Dec 3, 2009. Available at:.
23. Burger D, Dayer JM,. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann NY Acad Sci 2002; 966: 464-473. (Pubitemid 34729207)
24. Chien JY, Jerng JS, Yu CJ, Yang PC,. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005; 33: 1688-1693.
25. Vermont CL, den Brinker M, Kakeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA,. Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med 2005; 33: 1610-1615. (Pubitemid 40980620)
26. Srinivas RV, Birkedal B, Owens RJ, Anantharamaiah GM, Segrest JP, Compans RW,. Antiviral effects of apo A-I and its synthetic amphipathic peptide analogs. Virology 1990; 176: 48-57. (Pubitemid 20149667)
27. Srinivas RV, Venkatachalapathi YV, Rui Z, Owens RJ, Gupta KB, Srinivas SK, Anantharamaiah GM, Segrest JP, Compans RW,. Inhibition of virus induced cell fusion by apo A-I and its amphipathic peptide analogs. J Cell Biochem 1991; 45: 224-237.
28. Alonso-Villaverde C, Segues T, Coll-Crespo B, Perez-Bernalte R, Rabassa A, Gomila M, Parra S, Gozalez-Esteban MA, Jimenez-Exposito MJ, Masana L,. High density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy. AIDS 2003; 17: 1173-1178. (Pubitemid 36667760)
29. Kim S, Kim M, Shin B, Na H, Choi J, Kee M, Chong S, Nam M,. Different isoforms of apo AI present heterologous post-translational expression in HIV infected patients. J Proteome Res 2007; 6: 180-184. (Pubitemid 46173670)
30. Owens RJ, Anantharamaiah GM, Kahon JB, Srinivas RV, Compans RW, Segrest JP,. Apo AI and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest 1990; 86: 1142-1150. (Pubitemid 20370419)
31. Stanislawski L, De Nechaud B, Christel P,. Plasma protein adsorption to artificial ligament fibers. J Biomed Mater Res 1995; 29: 315-323.
32. Knetsch MLW, Aldenhoff YBJ, Koole LH,. The effect of high-density- lipoprotein on thrombus formation on and endothelial cell attachment to biomaterial surfaces. Biomaterials 2006; 27: 2813-2819. (Pubitemid 43165750)
33. Knight LC, Budzynski AZ, Olexa SA,. Radiolabelling of fibrinogen using the iodogen technique. Thromb Haemost 1981; 46: 593-596. (Pubitemid 11026286)
34. Pierce Chemical Company. Rockford, IL, USA. IODO-GEN Iodination Reagent, 1993.
35. Regoeczi E,. Iodine-labeled Plasma Proteins, Vol 1. Boca Raton, FL: CRC Press; 1984.
36. Archambault JG, Brash JL,. Protein repellent polyurethane-urea surfaces by chemical grafting of hydroxyl-terminated poly(ethylene oxide): Effects of protein size and charge. Colloids Surf B Biointerfaces 2004; 33: 111-120. (Pubitemid 38115183)
37. Cornelius RM, McClung WG, Barre P, Esguerra F, Brash JL,. Effects of bleach/formaldehyde reprocessing on polysulfone and polyamide hemodialysers. ASAIO J 2002; 48: 300-311. (Pubitemid 35006995)
38. Babensee JE, Cornelius RM, Brash JL, Sefton MV,. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: Human serum proteins in vitro and rat proteins following implantation. Biomaterials 1998; 19: 839-849. (Pubitemid 28276635)
39. Van Raamsdonk JM, Cornelius RM, Brash JL, Chang PL,. Deterioration of polyamino acid-coated alginate microcapsules in vivo. J Biomater Sci Polym Ed 2002; 13: 863-884. (Pubitemid 35345391)
40. Shen F, Aihua Li A, Cornelius RM, Cirone P, Childs RF, Brash JL, Chang PL,. Biological properties of photocrosslinked alginate microcapsules. J Biomed Mater Res B Appl Biomater 2005; 75B: 425-434. (Pubitemid 41609565)
41. Du YJ, Brash JL, McClung G, Berry LR, Klement P, Chan AKC,. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex. J Biomed Mater Res 2007; 80A: 216-225. (Pubitemid 44913349)
42. Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HMK,. Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. PNAS 2006; 103: 2126-2131. (Pubitemid 43271634)
43. Kim J-K, Scott EA, Elbert DL,. Proteomic analysis of protein adsorption: Serum amyloid P adsorbs to materials and promotes leukocyte adhesion. J Biomed Mater Res 2005; 75A: 199-209. (Pubitemid 41298202)
44. Cornelius RM, Macri J, Brash JL,. Apo AI, a major player in blood material interactions. Annual Meeting, Society for Biomaterials, San Antonio, Texas; 2009.
45. Vroman L, Adams AL, Fischer GC, Munoz PC,. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 1980; 55: 156-159. (Pubitemid 10211912)
46. Brash JL, ten Hove P,. Effect of plasma dilution on adsorption of fibrinogen to solid surfaces. Thromb Haemost 1984; 51: 326-330. (Pubitemid 14097884)
47. Jin Z, Feng W, Zhu S, Sheardown H, Brash JL,. Protein-resistant polyurethane via surface-initiated atom transfer radical polymerization of oligo(ethylene glycol) methacrylate. J Biomed Mater Res 2009; 91A: 1189-1201.
48. Woodhouse KA, Brash JL,. Adsorption of plasminogen from plasma to lysine-derivatized polyurethane surfaces. Biomaterials 1992; 13: 1103-1108. (Pubitemid 23022909)
49. Ozsavci D, Yardimci T, Demirel GY, Uras F, Hekim N, Ulutin ON,. Apo A-I binding to platelets detected by flow cytometry. Thromb Res 2001; 103: 117-122. (Pubitemid 32701949)
50. Chmielewski M, Carrero JJ, Qureshi AR, Axelsson J, Heimburger O, Berglund L, Barany P, Rutkowski B, Lindholm B, Stenvinkel P,. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients. J Intern Med 2009; 265: 708-716.
51. Jamoussi K, Ayedi F, Abida N, Kamoun K, Feki H, Chaabouni MN, Hammouda F, Bahloul I, Bellaj A, Hachicha J, Ellouz F,. Lipid profiles in maintenance dialysis. Pathol Biol 2005; 53: 217-220.